Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab
Clinical trial NCT04114630 · WITHDRAWN
Trial details
- NCT number
- NCT04114630
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2021-12-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.